Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?
about
Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Does neoadjuvant doxorubicin d ...... for hepatocellular carcinoma?
@en
Does neoadjuvant doxorubicin d ...... for hepatocellular carcinoma?
@nl
type
label
Does neoadjuvant doxorubicin d ...... for hepatocellular carcinoma?
@en
Does neoadjuvant doxorubicin d ...... for hepatocellular carcinoma?
@nl
prefLabel
Does neoadjuvant doxorubicin d ...... for hepatocellular carcinoma?
@en
Does neoadjuvant doxorubicin d ...... for hepatocellular carcinoma?
@nl
P2093
P2860
P356
P1476
Does neoadjuvant doxorubicin d ...... for hepatocellular carcinoma?
@en
P2093
Colin P Cantwell
David P Brophy
Dimitri Dorcaratto
Donal Maguire
Jeffrey W McCann
Justin Geoghegan
Niamh M Hogan
Venkatesha Udupa
P2860
P304
P356
10.5152/DIR.2017.17106
P577
2017-10-24T00:00:00Z